HuagongsheHuagongshe Chemistry Print Report · For research reference only
4-Methylmorpholine → N-[(1R)-1-(5-chloro-1H-benzimidazol-2-yl)-2-methoxy-ethyl]-3-methyl-4-(5-oxo-[1,4]oxazepan-4-yl)-benzamide
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | 4-Methylmorpholine | HCID 7972 | — |
| Reactant | O-(Benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium tetrafluoroborate | HCID 2733207 | — |
| Reactant | 3-Methyl-4-(5-oxo-[1,4]oxazepan-4-yl)benzoic acid | HCID 67048325 | — |
| Reactant | HCID 178495727 | HCID 178495727 | — |
| Solvent | Dimethylformamide | HCID 6228 | — |
| Product | N-[(1R)-1-(5-chloro-1H-benzimidazol-2-yl)-2-methoxy-ethyl]-3-methyl-4-(5-oxo-[1,4]oxazepan-4-yl)-benzamide | HCID 178495745 | — |
Reaction Steps
Prepared analogously to Example 1f from 3-methyl-4-(5-oxo-[1,4]oxazepan-4-yl)benzoic acid, (1R)-1-(5-chloro-1H-benzimidazol-2-yl)-2-methoxy-ethylamine, TBTU and NMM in DMF with subsequent purification by preparative HPLC.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US07947700B2 |
| Source dataset | uspto-grants-2011_05 |
| ORD ID | ord-764eebb67f954c939bf2622a9547806c |
| Source note | uspto-grants-2011_05 |